Cadensee

JULY 26, 2021

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. We established a wholly owned subsidiary in the US and we have an office in San Diego with sales and marketing personnel. So, this was a prospective, randomized, double blind, placebo-controlled study. So, not a dull moment, I tell you.

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3.

Medical 98

Medical Manufacturing Insurance Side effects 98